MK-2894
Modify Date: 2024-01-09 21:54:20
MK-2894 structure
|
Common Name | MK-2894 | ||
|---|---|---|---|---|
| CAS Number | 1006036-87-8 | Molecular Weight | 473.50700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H22F3NO3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MK-2894MK-2894 is a highly potent and selective second generation EP4 antagonist.IC50 value:Target: EP4MK-2894 exhibits favorable pharmacokinetic profile in a number of preclinical species and potent anti-inflammatory activity in several animal models of pain/inflammation. MK-2894 also shows favorable GI tolerability profile in rats when compared to traditional NSAID indomethacin. |
| Name | 4-[1-[[2,5-dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]thiophene-3-carbonyl]amino]cyclopropyl]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | MK-2894 is a highly potent and selective second generation EP4 antagonist.IC50 value:Target: EP4MK-2894 exhibits favorable pharmacokinetic profile in a number of preclinical species and potent anti-inflammatory activity in several animal models of pain/inflammation. MK-2894 also shows favorable GI tolerability profile in rats when compared to traditional NSAID indomethacin. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C25H22F3NO3S |
|---|---|
| Molecular Weight | 473.50700 |
| Exact Mass | 473.12700 |
| PSA | 98.13000 |
| LogP | 6.66660 |
| Storage condition | 2-8℃ |
| MK-2894||MK2894 |
| MK-2894 |
| 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid |
| CS-0679 |